Kiora Pharmaceuticals, Inc. (KPRX)
2.08
-0.06
(-2.80%)
USD |
NASDAQ |
Feb 12, 16:00
2.055
-0.02
(-1.20%)
After-Hours: 20:00
Kiora Pharmaceuticals EPS Diluted (Quarterly) : 0.0062 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | -1.009 |
| Plus Therapeutics, Inc. | -0.0412 |
| Atossa Therapeutics, Inc. | -1.009 |
| Abeona Therapeutics, Inc. | -0.0952 |
| Cell Source, Inc. | -0.021 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.0268M |
| Total Expenses (Quarterly) | -0.0268M |
| Enterprise Value | -11.32M |
| Earnings Yield | -118.3% |
| Normalized Earnings Yield | -126.41 |